skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice

Abstract

Toll-like receptor 4 (TLR4) activation has been proposed to be important for islet cell inflammation and eventually β cell loss in the course of type 1 diabetes (T1D) development. However, according to the “hygiene hypothesis”, bacterial endotoxin lipopolysaccharide (LPS), an agonist on TLR4, inhibits T1D progression. Here we investigated possible mechanisms for the protective effect of LPS on T1D development in non-obese diabetic (NOD) mice. We found that LPS administration to NOD mice during the prediabetic state neither prevented nor reversed insulitis, but delayed the onset and decreased the incidence of diabetes, and that a multiple-injection protocol is more effective than a single LPS intervention. Further, LPS administration suppressed spleen T lymphocyte proliferation, increased the generation of CD4{sup +}CD25{sup +}Foxp3{sup +} regulatory T cells (Tregs), reduced the synthesis of strong Th1 proinflammatory cytokines, and downregulated TLR4 and its downstream MyD88-dependent signaling pathway. Most importantly, multiple injections of LPS induced a potential tolerogenic dendritic cell (DC) subset with low TLR4 expression without influencing the DC phenotype. Explanting DCs from repeated LPS-treated NOD mice into NOD/SCID diabetic mice conferred sustained protective effects against the progression of diabetes in the recipients. Overall, these results suggest that multiple mechanisms are involved in the protectivemore » effects of LPS against the development of diabetes in NOD diabetic mice. These include Treg induction, down-regulation of TLR4 and its downstream MyD88-dependent signaling pathway, and the emergence of a potential tolerogenic DC subset. - Highlights: • Administration of lipopolysaccharide (LPS) prevented type 1 diabetes in NOD mice. • Downregulating TLR4 level and MyD88-dependent pathway contributed to protection of LPS. • LPS administration also hampered DC maturation and promoted Treg differentiation.« less

Authors:
 [1];  [1];  [2]; ; ; ;  [1];  [1]
  1. Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (China)
  2. Section of Neurobiology, Torrey Pines Institute for Molecular Studies, Port Saint Lucie, FL (United States)
Publication Date:
OSTI Identifier:
22465768
Resource Type:
Journal Article
Journal Name:
Toxicology and Applied Pharmacology
Additional Journal Information:
Journal Volume: 285; Journal Issue: 3; Other Information: Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); Journal ID: ISSN 0041-008X
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; BONE MARROW; DENDRITES; ENZYMES; EOSIN; HEMATOXYLIN; HISTOCOMPATIBILITY COMPLEX; HYPOTHESIS; INFLAMMATION; INJECTION; INTERFERON; LOSSES; LYMPHOCYTES; MICE; PHENOTYPE; RECEPTORS; SAFETY; SPLEEN

Citation Formats

Wang, Jun, Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, Cao, Hui, Wang, Hongjie, Yin, Guoxiao, Du, Jiao, Xia, Fei, Lu, Jingli, and Xiang, Ming. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice. United States: N. p., 2015. Web. doi:10.1016/J.TAAP.2015.04.006.
Wang, Jun, Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, Cao, Hui, Wang, Hongjie, Yin, Guoxiao, Du, Jiao, Xia, Fei, Lu, Jingli, & Xiang, Ming. Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice. United States. https://doi.org/10.1016/J.TAAP.2015.04.006
Wang, Jun, Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan, Cao, Hui, Wang, Hongjie, Yin, Guoxiao, Du, Jiao, Xia, Fei, Lu, Jingli, and Xiang, Ming. Mon . "Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice". United States. https://doi.org/10.1016/J.TAAP.2015.04.006.
@article{osti_22465768,
title = {Multiple mechanisms involved in diabetes protection by lipopolysaccharide in non-obese diabetic mice},
author = {Wang, Jun and Department of Pharmacology, College of Medicine, Wuhan University of Science and Technology, Wuhan and Cao, Hui and Wang, Hongjie and Yin, Guoxiao and Du, Jiao and Xia, Fei and Lu, Jingli and Xiang, Ming},
abstractNote = {Toll-like receptor 4 (TLR4) activation has been proposed to be important for islet cell inflammation and eventually β cell loss in the course of type 1 diabetes (T1D) development. However, according to the “hygiene hypothesis”, bacterial endotoxin lipopolysaccharide (LPS), an agonist on TLR4, inhibits T1D progression. Here we investigated possible mechanisms for the protective effect of LPS on T1D development in non-obese diabetic (NOD) mice. We found that LPS administration to NOD mice during the prediabetic state neither prevented nor reversed insulitis, but delayed the onset and decreased the incidence of diabetes, and that a multiple-injection protocol is more effective than a single LPS intervention. Further, LPS administration suppressed spleen T lymphocyte proliferation, increased the generation of CD4{sup +}CD25{sup +}Foxp3{sup +} regulatory T cells (Tregs), reduced the synthesis of strong Th1 proinflammatory cytokines, and downregulated TLR4 and its downstream MyD88-dependent signaling pathway. Most importantly, multiple injections of LPS induced a potential tolerogenic dendritic cell (DC) subset with low TLR4 expression without influencing the DC phenotype. Explanting DCs from repeated LPS-treated NOD mice into NOD/SCID diabetic mice conferred sustained protective effects against the progression of diabetes in the recipients. Overall, these results suggest that multiple mechanisms are involved in the protective effects of LPS against the development of diabetes in NOD diabetic mice. These include Treg induction, down-regulation of TLR4 and its downstream MyD88-dependent signaling pathway, and the emergence of a potential tolerogenic DC subset. - Highlights: • Administration of lipopolysaccharide (LPS) prevented type 1 diabetes in NOD mice. • Downregulating TLR4 level and MyD88-dependent pathway contributed to protection of LPS. • LPS administration also hampered DC maturation and promoted Treg differentiation.},
doi = {10.1016/J.TAAP.2015.04.006},
url = {https://www.osti.gov/biblio/22465768}, journal = {Toxicology and Applied Pharmacology},
issn = {0041-008X},
number = 3,
volume = 285,
place = {United States},
year = {2015},
month = {6}
}